OLFM2 and metabolic dysfunction-associated steatotic liver disease: Since we previously suggested a possible implication of hepatic OLFM2 in NAFLD progression, we now propose a possible interaction between the OLFM2 of SAT and the liver, reinforcing the fact that a SAT–liver axis may be implicated in NAFLD development.